We dive into the hype surrounding GLP-1 and GIP weight loss drugs like Ozempic, Wegovy and Mounjaro. With commercials and social media buzzing about these medications, we ask the important questions: Do they really work long-term? Who should be taking them? And what are the potential risks? Joining us is Dr. Efstratios Koutroumpakis, Assistant Professor of Medicine at MD Anderson Cancer Center, to break down the science, benefits, and potential dangers of these popular drugs.